Life Sciences

Worcester has experienced Boston-sized population growth over the last decades, creating not only major opportunities for businesses but urban growing pains along with it.

Informal meetings take place across Worcester everyday with the express goal of uplifting a Gateway City on the brink of larger economic and cultural significance.

The research team, headed by UMass Chan neurology professors Brigitte van Zundert and Robert Brown discovered in a mouse study that a toxin known as polyP is a likely contributor to motor neuron death.

Marlborough medical device manufacturer Hologic Inc. partnered with the Women’s Tennis Association to further the company’s focus on women’s wellness and equality.

Two Worcester institutions received more than $5 million in grants from the Massachusetts Life Sciences Center, which on Thursday announced $28.3 million in capital funding to institutions across the state.

The City of Fitchburg has received the Platinum Certification from the Massachusetts Biotechnology Institute (MassBio), further cementing its status as a community that openly welcomes biotech companies.

Marlborough drugmaker Phio Pharmaceuticals has begun animal studies on an antiviral compound as a potential treatment for SARS-CoV-2 infection, the virus that causes COVID-19.

Steve Rotman, the 82-year-old CEO of Worcester manufacturer Vystar Corp., is restructuring his companies as part of a larger effort to transition to a new leader of the parent company with holdings including his family business Rotmans Furniture.

Worcester Polytechnic Institute has joined BioConnects New England, a regional coalition to support biotechnology hubs throughout New England.

Variantyx, a Framingham firm specializing in advanced genomic testing for rare genetic disorders, reproductive health, and precision oncology, has secured $41.5 million in additional funding to advance its rapidly growing global precision oncology business.